Mucoral mast cells (MMC) are found mainly wilhin Ihe jejunal submuasa M M C increase in inleslinal graft.versur-host reaction. and their degranulation i s observed In paraslltc enleropalhy. Weanlng I s asroclaled wlth morpho9lcal changes resembling those seen in mild cell,mediated inleslinal injury. W e studied M M C in lhe young rat jejunum In relation l o weaning changes. Jejunal morphology. aypl cell production rate, inlraepilhelial lymphocylec (IEL) and goblet cells woro ctudied.
and M M C were cnunled in rat mast cell prolease I1 antibody (anli.RMCP 11) and toluidine blue stained sedions. Serum R M C P I 1 was delermined with a direct ELlSA method. In Ihe nexl few days follawlng weaning Ihe jejunal villi shorlened by about 30%. crypts elongated by the same amount. aypl cell produc lion rale more than doubled. and the numbers of IEL showed a marked increase. The M M C aunls showed a steady Increase from birth lo the lime of weaning. sharp fall on the two days immediately after weaning. and further increase thereafler. Serum R M C P I1 level displayed a sudden rise at the lime of weaning.
wilh eradual decline thereafler. Muasal masl cell deeranulalion. obviously associaled wilh the event of weaning, may be responsible for the observed morphological changes through epilhelial cell damage. Weanlng Is a period of lemporary loss of oral lolerance In rals: this mlghl be a resull of (elunal Inlury caused by muasal masl cell protease.
SMALL INTESTINE TRANSPLANTATION IN A CHILD
Hopital des Enfants Malades Paris France. After an experimental stage on piglets small intestine transplantation(S1T)using Cyclosporine A(CsA)we now report a human case.A 9 yrs old gir1,on home parenteral nutrition for short small bowel (volvulus)for 6 yrs was transplanted with 120cm small intestine harvested by an isoblood group A 17 yrs old boy pronouced brain dead.Cross match reaction donor and recipient was negative.After aorta and inferior vena cava anastomosis total ischemic time was 3h55mn;both graft and own intestine were exteriorized as stomas. Immunosuppression included solumedrol Zmg/kg/d and CsA as a continuous infusion to maintain serum levels between 200-300pg/l.Acute graft rejection(GR)occured on day 13 marked only with an increased ileostomy drainage;histologic pattern included progressively=villi oedema,Tcell infiltrates(~~4+/~~8+) .increased HLAOR expression by enterocyte6,severe crypt damage and ultimately mucosal sloughing.GR was treated with antilymphocyte globulin.No GVH reaction has been observed.The course after CR was marked with a persistant protein losing enteropathy up to a progressive intestine recovery as shown by repeated histologic findings,baryum transit(day 30 and 80)and start oral feeding from day 60.Unfortunately from the 6'month the addition of prolonged CsA IV administration,long term PN and probable viral infection induced severe liver disease and hematologic disorders requiring graft removal after 61 months.The patient died.This course demonstrate that 6 months survival is possible after SIT.Smal1 bowel recovery can be achieved despite extensive mucosal destruction caused be acute graft rejection.
COMPARISON OF RETICULIN (ARA) AND ENDOMYSIUM
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(EHA) ANTIBODIES IN COELIAC DISEASE.
Maki M, Hallstrom 0. Polanco I, Visakorpi JK.
Departments of Microbiology and Paediatrics, University Central Hospital of Tampere, Finland and Hospital Infantil "La Paz", Madrid. Spain
IgA class ARA and EMA are both suggested to be good indicators of villous atrophy in coeliac disease (CD). We have now done the tests parallelly in children with untreated CD (521, on gluten-free diet (20) and during gluten challenge (10). Children (50) biopsied because of suspected CD and uith normal mucosa served as controls. Furthermore 100 adult blood donors were tested. Children uith untreated CD were both ARA and EMA positive (titres 1:10 to 1:BOOO for both). 5 children with IgA deficiency and flat intestinal nucosa uere negative for both tests. During gluten-free diet disappearance of both ARA and EMA correlated well with mucosal recovery. 4 children with normal mucosa were found to have these antibodies in titres 1:5 to 1:200. They all were brothers and sisters to CD patients. All the others uere ARA and EMA negative. One of the blood donors was positive for both tests. On biopsy, subtotal villous atrophy was found. The absorption of antibodies from patient sera uith animal and human tissues and retesting results suggest the antigens for ARA and EMA not to be fully identical. However, in clinical practise no difference betueen ARA and EMA could be seen. gluten-containing diet (GCD) are immunologically tolerant to gliadin (1). Aim of this study was to investigate whether oral tolerance is recreated in each generation by the ingestion of dietary gluten at weaning, or whether it is transferred from mother to young (as immune status or via passage of antigen) before birth or during lactation. BALB/c mice were used, reared on a gluten-free diet (GTD), born to mothers either from a GFD or a GCD colony. After parenteral immunisation with gliadin, both humoral and cell-mediated immunity were assessed by serun antibody (ELISA) and footpad swelling test, respectively. Unexpectedly, mice born to mothers from a E D colony showed systemic immune responses to gliadin significantly higher ip(0.05) than mice born to mothers from a GFD colony. Furthermore, feeding mothers GCD for defined periods before and during pregnancy and during lactation, also resulted in priming of the specific immune responses of the offspring. These findings indicate that, in mice, sensitisation to maternal dietary antigens occurs in utero or shortly after birth. This animal model should allow investigation of the immunological mechanisms concerned. Hospital, Edinburgh, Scotland, UK Mucosal CMI to gliadin is likely to be implicated in the pathogenesis of coeliac disease. Our a h kas to induce mucosal CMI to gliadin by feeding gluten-containing diet (GCD) to mice previously parenterally immunised with this antigen. BALBlc mice from a gluten-free diet (GTDI colony were used. They were given parenterally gliadln in complete Freund's adjuvant, and 3 weeks later they were challenged wlth GCD for 7 days. In further experiments the effect of concurrent G W reaction was evaluated in BDFl mice on a ED, previously immunised with gliadin. CMI responses in small intestinal mucosa were measured by morphometry (villous and crypt length, crypt cell production rate ICCPR), and lntraepithelial lymphocytes IIEL) count). Feeding GCD for a week to mice reared on GTD did not produce any change. Similarly, mice given GCD after having been parenterally innunised with gliadin did not show mucosal CMI. Mice on GCD given both gliadin immunisation and G W showed a significant increase (~(0.05) in crypt depth, CCPR and IEL count, in comparison to ccrLrols given only GVH. These results indicate that systemic immunity to gliadin is not sufficient to induce specific intestinal CHI. Additional factors (enhanced antigen presentation, increased intestinal permeability) are also necessary. Giphart .
IN MICE, GLUTEN IN HATERNAL DIET PRIMES SYSTEMIC IMMUNE RESWNSES
Depts. of Imnunohaematology and Blood Bank and *Gastroenterology, University Hospital, Leiden. The Netherlands.
Susceptibility genes for coeliac disease are associated with certain HLA-DR genotypes. More recent studies also show strong association with some HLA-DQ alleles. We have examined the presence of disease associated HLA-DQ alleles by restriction fragment length polymorphism (RFPL) with the help of a HLA-DQ alpha cDNA probe. This probe showed upon hybridization a highly significant discrepancy between the RFLP of coeliac disease patients and healthy controls. The 4.0 kb. Bgl I1 restriction fragment was present in 97% of coeliac disease patients (n-30). compared to 56% in a healthy control population (11-72) (RR-14.9; p<0.0005). This fragment is associated with HLA-DR3, -5 , some DRw8, and DRw14Du16. This was confirmed by the analysis of the panel of 72 homozygous typing cells obtained from the Xth International Workshop on Histocompatibility Testing. At the product level all coeliac diseaae patients tested sofar have one DQ alpha chain in common, designated HLA-DQ alpha 2.3, which is associated with the 4.0 kb Bgl I1 fragment. This HLA-DQ alpha allele identified at the DNA level and product level seems to be a better marker for genetic susceptibility to develop coeliac disease than those available sofar.
